返回
R
Ron Blankstein
harvard medical school
5H指数
29论文数
184被引数
收录论文 9
发表时间
Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristicsRATIONALE AND DESIGN OF THE REMBRANDT TRIAL: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics: REMBRANDT试验的原理与设计:一项评估obicetrapib/ezetimibe对冠状动脉斑块特征影响作用的III期研究

